← Back to patent-cliff list
CAS 608-31-1
2,6-Dichloroaniline
Codes:(I)122568-1-a、(VI)122568-3-a、(III)122568-4-a、(V)122568-5-a
Application context (from source-drug indications)
注意力缺陷障碍伴多动盐酸可乐定 (Tris Pharma)高血压盐酸可乐定 (Tris Pharma)
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 盐酸可乐定 (Tris Pharma)Clonidine Hydrochloride (Tris Pharma) | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-Mercaptoimidazoline→1,1-Dimethylethyl monobromoacetate→tert-Butyl [(4,5-dihydro-1H-imidazol-2-yl)sulfanyl]acetate hydrogen bromide→Methyl 2-[(2-tert-butoxy-2-oxoethyl)sulfanyl]-4,5-dihydro-1H-imidazole-1-carboxylate→2,6-Dichloroaniline
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.